Hereditary Testing Market Size Worth US$ 9.29 Billion by 2027 | CAGR: 6.2%

The globalhereditary testing market预计根据Polaris市场研究的一项新的研究，2027年将达到92.9亿美元。betway苹果下载那个报告“遗传检测市场份额，规模，趋势，行业分析报告，通过疾病型（遗传性癌症检测，遗传性非癌症检测;通过技术（细胞遗传学，生化，分子测试）;按地区;段预测，2020 - 2027”gives a detailed insight into current market dynamics and provides analysis on future market growth.

越来越需要及时诊断遗传遗传性疾病，并通过关键参与者推出成本效益的治疗方案是负责市场增长的关键因素。据致力于稀有疾病的组织发布的市场统计数据，超过3000多万人目前正在遭受大约6,000种罕见的罕见疾病。

预计实验室利用生物信息学基于云的分布模型的技术进步预计对遗传测试的生长产生积极影响。此外，预计跨越发发经济体的遗传测试的试验量增加将推动在预测期间对遗传检测的市场需求。

Have Questions? Request a sample or make an Inquiry before buying this report by clicking the following link://m.jiayuancx.com/Industry-anysission/heredity-Testing-market/Request-for-sample.

Segment Highlights

• The hereditary cancer testing market segment accounted for the largest revenue segment in 2019 owing to the increasing genetic tests for cancer in developed economies such as the U.S., UK, Canada, and France, among others
• Europe market accounted for the largest revenue share in 2019 owing to the increasing tests across the region and technological advancement in the field of testing is expected to drive the market growth of hereditary tests over the forecast period

钥匙播放器列表

• 米yriad Genetics, Inc.
• Invitae Corporation
• Illumina，Inc。
• Natera，Inc。
• Hoffmann-La Roche Ltd
• Quest Diagnostics.
• Agilent Technologies, Inc.
• Twist Bioscience
• 索菲亚遗传学
• Fulgent Genetic, Inc.
• 米edgenome
• CENTOGENE N.V.
• 其他

Polaris Market Research has segmented the hereditary testing market report on the basis of disease type, technology, and region

Hereditary Testing, Disease Type Outlook (Revenue – USD Million, 2016 – 2027)

• 遗传性癌症测试
  • Lung Cancer
  • 乳腺癌
  • Colorectal Cancer
  • Cervical Cancer
  • Ovarian Cancer
  • 前列腺癌
  • 胃/胃癌
  • 黑色瘤
  • Sarcoma
  • 子宫癌
  • Pancreatic Cancer
  • 其他
• Hereditary Non-Cancer Testing
  • Genetic Tests
    • 心脏病疾病
    • 稀有疾病
    • 其他疾病
  • Newborn Genetic Screening
  • Preimplantation Genetic Diagnosis & Screening
  • Non-invasive Prenatal Testing (NIPT) & Carrier Screening Tests

Hereditary Testing, Technology Outlook (Revenue – USD Million, 2016 – 2027)

• 细胞遗传学测试
• Biochemical Testing
• 分子测试

遗传检测区域前景（收入 - 百万，2016 - 2027）

• 北美
  • U.S.
  • Canada
• Europe
  • France
  • Germany
  • 英国
  • Italy
  • Spain
  • 荷兰
  • 奥地利
• 亚太地区
  • 中国
  • India
  • 日本
  • 米alaysia
  • 韩国
  • 印度尼西亚
• 中美洲和南美洲
  • 米exico
  • Brazil
  • Argentina
• 中东和非洲
  • 阿联酋
  • 沙特阿拉伯
  • Israel
  • 南非